// App-Quantinova.ai

BSH19‐PO‐038 : Prescribing Practice and Clinical Outcomes in a real‐world Chronic Myeloid Leukaemia Regional Cohort

Researchers

Presenter

  • U. Reddy

Principal Investigators

  • K. De Abrew

  • K.L. Mak

  • D. Rahman

  • H.J. Liew

  • B. Gray

  • E. Belsham

  • R. Ayto

Medical Centers

  • Rheumatology Dept, Portsmouth Hospitals NHS Trust, Portsmouth

  • Haematology, Salisbury District Hospital, Salisbury

  • Haemophilia, Basingstoke and North Hampshire Hospitals, Basingstoke, UK

  • Haematology, Southampton General Hospital, Southampton

  • Royal Bournemouth Hospital, Bournemouth, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic Myelogenous Leukemia

Biomarkers

  • Abelson murine leukemia viral oncogene homolog

  • Breakpoint Cluster Region

Drug/Treatment

  • Nilotinib

  • Ponatinib

  • dasatinib

  • Imatinib

  • IkT001

  • L-Tyrosine

  • TF-12

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved